Civic Intelligence

Tag Treatment Action Group Inc

EIN 13-3624785 • 501(c)3 • New York, NY

Profile

Treatment action group (tag) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and lgbtq+ equity; social justice; and liberation, fighting to end hiv, tuberculosis (tb), and hepatitis c virus (hcv).tag catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by hiv, tb, or hcv - especially communities of color and other marginalized communities experiencing inequities - receive life-saving prevention, diagnosis, treatment, care, and information.we are science-based activists working to expand and accelerate vital research and effective community engagement with research and policy institutions for an end to the hiv, tb, and hcv pandemics.

90 Broad Street 2503New York, NY 10004

www.treatmentactiongroup.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

66th percentile

0.19x

Higher debt load relative to assets than 66% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

67th percentile

0.21x

Higher debt load relative to revenue than 67% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

18th percentile

-14%

Higher net margin than 18% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

10th percentile

-17%

Faster asset growth than 10% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

12th percentile

-25%

Faster revenue growth than 12% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets66th percentile

Assets

Down

$3,839,139

Down $784,893 (-17%) from 2023

Liabilities

Down

$745,777

Down $267,172 (-26%) from 2023

Net Assets

Down

$3,093,362

Down $517,721 (-14%) from 2023

Operations
Liabilities / Revenue67th percentileNet Margin18th percentile

Revenue

Down

$3,574,921

Down $1,161,255 (-25%) from 2023

Expenses

Up

$4,092,642

Up $349,562 (+9.3%) from 2023

Net Income

Down

-$517,721

Down $1,510,817 (-152%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth10th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2024

Assets$3,839,139
Liabilities$745,777
Net Assets$3,093,362
Open 2024 Filing

Operations Trend

Revenue Growth12th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2024

Revenue$3,574,921
Expenses$4,092,642
Net Income-$517,721
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.

Open filing
Assets
$3,839,139
Liabilities
$745,777
Net assets
$3,093,362
Revenue
$3,574,921
Expenses
$4,092,642
Net income
-$517,721
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Oct 2, 2025
Return Version
2024v5.2
Gross Receipts
$3,619,941
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

Treatment action group (tag) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and lgbtq+ equity; social justice; and liberation, fighting to end hiv, tuberculosis (tb), and hepatitis c virus (hcv).tag catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by hiv, tb, or hcv - especially communities of color and other marginalized communities experiencing inequities - receive life-saving prevention, diagnosis, treatment, care, and information.we are science-based activists working to expand and accelerate vital research and effective community engagement with research and policy institutions for an end to the hiv, tb, and hcv pandemics.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$1,394,085$1,346,271▼ $47,814
Pledges and Grants Receivable$1,796,031$1,191,129▼ $604,902
Prepaid Expenses and Deferred Charges$72,871$76,668▲ $3,797
Cash and Non-Interest-Bearing Accounts$48,553$44,940▼ $3,613
Land, Buildings, and Equipment, Net$13,565$13,782▲ $217
Accounts Receivable$8,271--
Total Assets$4,624,032$3,839,139▼ $784,893
Other Assets Total$1,290,656$1,166,349▼ $124,307
Liabilities
Other Liabilities$938,942$673,629▼ $265,313
Accounts Payable and Accrued Expenses$74,007$72,148▼ $1,859
Total Liabilities$1,012,949$745,777▼ $267,172
Net Assets / Fund Balance
Net Assets With Donor Restrictions$1,836,044$1,609,499▼ $226,545
Net Assets Without Donor Restrictions$1,775,039$1,483,863▼ $291,176
Total Net Assets Fund Balance$3,611,083$3,093,362▼ $517,721
Total Liabilities and Net Assets / Fund Balance$4,624,032$3,839,139▼ $784,893

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$13,782$89,961$103,743
Other Assets Org$598,808--
Compensation and Service Providers
Top Officer PayScore unavailable

Employees

NameTitleFull / Part TimeBaseOtherTotal
Mark HarringtonExecutive DirectorFT$193,628$19,183$212,811
Elizabeth LovingerHealth Policy DirectorFT$104,918$54,555$159,473
Jason KirkChief Operating OfficerFT$128,184$19,183$147,367
Lindsay MckennaTb Program Co-directorFT$125,040$19,183$144,223
Mike FrickTb Program Co-directorFT$125,040$19,183$144,223
Christopher GeorgeDirector of FinanceFT$109,180-$109,180

Board Members and Trustees

NameTitle
Ivy Kwan ArcePresident
Ama BurnhamDirector
Bob BronzoDirector
David PuenteDirector
Dr Stefan GoldbergDirector
Jameel JiwaniDirector
Jim AquinoDirector
Joy EpisallaDirector
Julian ChungDirector
Karl SchmidDirector
Kevin GoetzDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Tanya WalkerDirector
Mrinal VikramSecretary
Laura MorrisonTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$3,477,949
Program Service Revenue
$29,185
Investment Income
$63,987
Other Revenue
$3,800
All Other Contributions
$3,211,514
Change in Net Assets
$-517,721

Audited Revenue Reconciliation

Revenue per Audited Statements
$3,574,921
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$3,574,921
Total Revenue per Form 990
$3,574,921
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$2,451,210
Other Expenses$955,015
Grants and Similar Amounts Paid$686,417
Total Fundraising Expense$295,797
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$1,269,800$187,683$71,440$1,528,923
Foreign Grants$678,109--$678,109
Other Employee Benefits$345,300$55,295$25,918$426,513
Current Officers, Directors, Trustees, and Key Employees$213,809$80,228$66,141$360,178
Fees for Services Other$267,403$21,404$14,049$302,856
Travel$199,802$4,595$11,254$215,651
Occupancy$119,702$26,250$12,922$158,874
Payroll Taxes$107,096$18,926$9,574$135,596
Information Technology$32,528$4,728$3,046$40,302
Office Expenses$17,081$4,152$10,851$32,084
Conferences and Meetings$30,700-$876$31,576
Insurance$18,252$4,003$1,970$24,225
Grants to Domestic Orgs$8,308--$8,308
Fees for Services Lobbying-$7,554-$7,554
Other Expenses$4,128$2,327$724$7,179
All Other Expenses-$45$7,074$7,119
Depreciation Depletion$3,767$826$407$5,000
Advertising$355$125$1,098$1,578
Total Functional Expenses$3,377,153$419,692$295,797$4,092,642

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$4,092,642
Total Expenses per Audited Statements$4,092,642
Total Expenses per Form 990$4,092,642
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
National Tb Controllers AssociationAtlanta, GA-Funds Paid Out as Fiscal Sponsor-tb Advocacy$8,308

International Summary

Offices
0
Employees
0
Spending
$789,377

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Sub-saharan AfricaGrantsTb Advocacy/cab Support00$333,374
South AsiaGrantsTb Advocacy/cab Support00$194,822
Europe (including Iceland and Greenland)GrantsTb Advocacy/cab Support00$126,734
South AsiaProgram ServicesTb - Global Tb Cab Meetings00$45,628
South AsiaProgram ServicesTb - Union Conference - Bali00$31,937
Sub-saharan AfricaGrantsHcv - Lat Cab/consultancy00$23,179
Sub-saharan AfricaProgram ServicesTb Advocacy/cab Support00$18,876
Sub-saharan AfricaProgram ServicesTb - Global Tb Cab Meetings00$10,708
Europe (including Iceland and Greenland)Program ServicesTb - Global Tb Cab Meetings00$1,778
Europe (including Iceland and Greenland)Program ServicesTb - Amr Conference - Switzerland00$1,620
Sub-saharan AfricaProgram ServicesHcv - Lat Cab00$721
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$45,020
Fundraising Gross Income$45,020
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$233,362$45,020-$45,020
Total Events$233,362$45,020$45,020$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Operating Lease Liability$673,629
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of directors before the return was filed with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”

Form 990, Part VI, Section B, Line 15

“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in march 2021.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET 2503, NEW YORK, NY 10004

Signing Officer

Name
Ivy Kwan Arce
Title
President
Phone
2122537922
Signed
2025-10-02
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Ivy Kwan Arce
Formed
1992
Legal Domicile
Ny
Voting Board Members
18
Independent Board Members
18
Employees
21
Volunteers
18

Preparer

Firm
Lutz and Carr Cpas Llp
Address
551 FIFTH AVE SUITE 400, NEW YORK, NY 10176
Preparer
Michael Wallace
Phone
2126972299
Supplemental Narrative

Financial Statement Notes

PART III, LINE 4:

“The art prints are sold as part of the ticket package for major donors of the research in action awards event and subsequently sold as individual editions.”

Raw XML AppendixShowing 400 of 840 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt074007
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt072148
IRS990/AccountsReceivableGrp/BOYAmt08271
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS.
IRS990/AdvertisingGrp/FundraisingAmt01098
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0125
IRS990/AdvertisingGrp/ProgramServicesAmt0355
IRS990/AdvertisingGrp/TotalAmt01578
IRS990/AllOtherContributionsAmt03211514
IRS990/AllOtherExpensesGrp/FundraisingAmt07074
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt045
IRS990/AllOtherExpensesGrp/TotalAmt07119
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0CHRISTOPHER GEORGE
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET SUITE 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt048553
IRS990/CashNonInterestBearingGrp/EOYAmt044940
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt066141
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt080228
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0213809
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0360178
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/FundraisingAmt0876
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt030700
IRS990/ConferencesMeetingsGrp/TotalAmt031576
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0188342
IRS990/CostOfGoodsSoldAmt00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt03477949
IRS990/CYGrantsAndSimilarPaidAmt0686417
IRS990/CYInvestmentIncomeAmt063987
IRS990/CYOtherExpensesAmt0955015
IRS990/CYOtherRevenueAmt03800
IRS990/CYProgramServiceRevenueAmt029185
IRS990/CYRevenuesLessExpensesAmt0-517721
IRS990/CYSalariesCompEmpBnftPaidAmt02451210
IRS990/CYTotalExpensesAmt04092642
IRS990/CYTotalFundraisingExpenseAmt0295797
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt03574921
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0407
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0826
IRS990/DepreciationDepletionGrp/ProgramServicesAmt03767
IRS990/DepreciationDepletionGrp/TotalAmt05000
IRS990/Desc0SEE SCHEDULE OTUBERCULOSIS (TB) PROGRAMACCORDING TO THE LATEST REPORT FROM THE WORLD HEALTH ORGANIZATION (WHO), IN 2023, TB PROBABLY RETURNED TO BEING THE WORLD'S LEADING CAUSE OF DEATH FROM A SINGLE INFECTIOUS AGENT, FOLLOWING 3 YEARS IN WHICH IT WAS REPLACED BY CORONAVIRUS DISEASE (COVID-19), AND CAUSED ALMOST TWICE AS MANY DEATHS AS HIV/AIDS. MORE THAN 10 MILLION PEOPLE CONTINUE TO FALL ILL WITH TB EVERY YEAR AND THE NUMBER HAS BEEN RISING SINCE 2021. URGENT ACTION IS REQUIRED TO END THE GLOBAL TB EPIDEMIC BY 2030, A GOAL THAT HAS BEEN ADOPTED BY ALL MEMBER STATES OF THE UNITED NATIONS (UN) AND THE WORLD HEALTH ORGANIZATION (WHO)." RECOGNIZING THAT MUCH MORE PROGRESS COULD BE MADE IF EXISTING TOOLS WERE FULLY IMPLEMENTED, AND THAT MORE RESEARCH IS NEEDED TO END TB, TAG'S TB PROGRAM STRENGTHENS EVIDENCE-DRIVEN AND HUMAN RIGHTS-BASED ADVOCACY BOTH FOR BETTER TB RESEARCH, AND FOR HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE, THAT MEET THE NEEDS OF AFFECTED COMMUNITIES.TAG'S TB PROGRAM EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE UNDERSTANDING OF TB AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROGRAM WORKS WITH COMMUNITY ADVOCATES, COMMUNITY ADVISORY BOARDS, RESEARCHERS, POLICY MAKERS, DEVELOPERS, AND DONORS TO ENSURE NEEDS-DRIVEN RESEARCH TO IMPROVE OPTIONS FOR TB PREVENTION, DIAGNOSIS, AND TREATMENT. THE TB PROGRAM PUBLISHES AN ANNUAL REPORT ON TB RESEARCH FUNDING TRENDS, AND ADVOCATES FOR ALL GOVERNMENTS OF THE WORLD TO STEP UP AND CONTRIBUTE THEIR "FAIR SHARE" INVESTMENTS IN TB R&D.THE TB PROGRAM WORKS WITH RESEARCHERS, ACTIVISTS, AND POLICYMAKERS AROUND THE WORLD TO ENSURE TRANSPARENCY AND UNIVERSAL, EQUITABLE, AFFORDABLE ACCESS TO PROVEN INTERVENTIONS, FROM EARLY IN THE RESEARCH PROCESS THROUGH REGULATORY APPROVAL TO GLOBAL AND NATIONAL GUIDELINES DEVELOPMENT AND PRODUCT PRICING. TAG'S POLICY TEAM SUPPORTS THE TB PROGRAM IN EDUCATING U.S. LEGISLATORS AND OFFICIALS ON TB PRIORITIES, AND LEADS DOMESTIC WORK AT THE LOCAL, STATE, AND NATIONAL LEVEL TO SUPPORT AMBITIOUS AND EVIDENCE-BASED PROGRAMMING TO END.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt01836044
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt01609499
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt021
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt02150585
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesLobbyingGrp/ManagementAndGeneralAmt07554
IRS990/FeesForServicesLobbyingGrp/TotalAmt07554
IRS990/FeesForServicesOtherGrp/FundraisingAmt014049
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt021404
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0267403
IRS990/FeesForServicesOtherGrp/TotalAmt0302856
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0678109
IRS990/ForeignGrantsGrp/TotalAmt0678109
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt04.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt53.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt93.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt101.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt124.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt132.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt143.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt151.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt160.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2240.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd16X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1719183
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1819183
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1919183
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2019183
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt210
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2254555
IRS990/Form990PartVIISectionAGrp/PersonNm0IVY KWAN ARCE
IRS990/Form990PartVIISectionAGrp/PersonNm1LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm2MRINAL VIKRAM
IRS990/Form990PartVIISectionAGrp/PersonNm3JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm4AMA BURNHAM
IRS990/Form990PartVIISectionAGrp/PersonNm5BOB BRONZO
IRS990/Form990PartVIISectionAGrp/PersonNm6JULIAN CHUNG
IRS990/Form990PartVIISectionAGrp/PersonNm7NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm8JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm9KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm10DR STEFAN GOLDBERG
IRS990/Form990PartVIISectionAGrp/PersonNm11JAMEEL JIWANI
IRS990/Form990PartVIISectionAGrp/PersonNm12RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm13ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm14DAVID PUENTE
IRS990/Form990PartVIISectionAGrp/PersonNm15KARL SCHMID
IRS990/Form990PartVIISectionAGrp/PersonNm16TANYA WALKER
IRS990/Form990PartVIISectionAGrp/PersonNm17MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm18JASON KIRK
IRS990/Form990PartVIISectionAGrp/PersonNm19LINDSAY MCKENNA
IRS990/Form990PartVIISectionAGrp/PersonNm20MIKE FRICK
IRS990/Form990PartVIISectionAGrp/PersonNm21CHRISTOPHER GEORGE
IRS990/Form990PartVIISectionAGrp/PersonNm22ELIZABETH LOVINGER
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt17193628
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt18128184
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt19125040
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20125040
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt21109180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt22104918
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt210
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt220
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt17EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt18CHIEF OPERATING OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt19TB PROGRAM CO-DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt20TB PROGRAM CO-DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt21DIRECTOR OF FINANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt22HEALTH POLICY DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0188342
IRS990/FundraisingDirectExpensesAmt045020
IRS990/FundraisingGrossIncomeAmt045020
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt018
IRS990/GovernmentGrantsAmt078093
IRS990/GrantAmt0654930
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt08308
IRS990/GrantsToDomesticOrgsGrp/TotalAmt08308
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt03619941
IRS990/GrossSalesOfInventoryAmt03800
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt018
IRS990/IndivRcvdGreaterThan100KCnt06
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt03046
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt04728
IRS990/InformationTechnologyGrp/ProgramServicesAmt032528
IRS990/InformationTechnologyGrp/TotalAmt040302
IRS990/InsuranceGrp/FundraisingAmt01970
IRS990/InsuranceGrp/ManagementAndGeneralAmt04003
IRS990/InsuranceGrp/ProgramServicesAmt018252
IRS990/InsuranceGrp/TotalAmt024225
IRS990/InvestmentIncomeGrp/ExclusionAmt063987
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt063987
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt022
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt089961
IRS990/LandBldgEquipBasisNetGrp/BOYAmt013565
IRS990/LandBldgEquipBasisNetGrp/EOYAmt013782
IRS990/LandBldgEquipCostOrOtherBssAmt0103743
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS.
IRS990/MoreThan5000KToIndividualsInd01
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt03611083
IRS990/NetAssetsOrFundBalancesEOYAmt03093362
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/ExclusionAmt03800
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt03800
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01775039
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01483863
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt012922
IRS990/OccupancyGrp/ManagementAndGeneralAmt026250
IRS990/OccupancyGrp/ProgramServicesAmt0119702
IRS990/OccupancyGrp/TotalAmt0158874
IRS990/OfficeExpensesGrp/FundraisingAmt010851
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt04152
IRS990/OfficeExpensesGrp/ProgramServicesAmt017081
IRS990/OfficeExpensesGrp/TotalAmt032084
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt01290656
IRS990/OtherAssetsTotalGrp/EOYAmt01166349
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt025918
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt055295
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0345300
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0426513
IRS990/OtherExpensesGrp/Desc0FUNDRAISING EVENTS
IRS990/OtherExpensesGrp/Desc1PRINTING & PUBLICATIONS
IRS990/OtherExpensesGrp/Desc2DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc3MISCELLANEOUS
IRS990/OtherExpensesGrp/FundraisingAmt053081
IRS990/OtherExpensesGrp/FundraisingAmt15287
IRS990/OtherExpensesGrp/FundraisingAmt285
IRS990/OtherExpensesGrp/FundraisingAmt3724
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0421
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt11130
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt22327
IRS990/OtherExpensesGrp/ProgramServicesAmt039142
IRS990/OtherExpensesGrp/ProgramServicesAmt121871
IRS990/OtherExpensesGrp/ProgramServicesAmt24128
IRS990/OtherExpensesGrp/TotalAmt053081
IRS990/OtherExpensesGrp/TotalAmt144850
IRS990/OtherExpensesGrp/TotalAmt223086
IRS990/OtherExpensesGrp/TotalAmt37179
IRS990/OtherLiabilitiesGrp/BOYAmt0938942
IRS990/OtherLiabilitiesGrp/EOYAmt0673629
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt071440
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0187683
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt01269800
IRS990/OtherSalariesAndWagesGrp/TotalAmt01528923
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt09574
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt018926
IRS990/PayrollTaxesGrp/ProgramServicesAmt0107096
IRS990/PayrollTaxesGrp/TotalAmt0135596
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt01796031
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01191129
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt072871
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt076668
IRS990/PrincipalOfficerNm0IVY KWAN ARCE
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0OTHER PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt029185
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt029185
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHIV PROGRAMACCORDING TO THE JULY 2025 UNAIDS GLOBAL AIDS REPORT, "40.8 MILLION [37.0 MILLION-45.6 MILLION] PEOPLE GLOBALLY WERE LIVING WITH HIV IN 2024. 1.3 MILLION [1 MILLION-1.7 MILLION] PEOPLE BECAME NEWLY INFECTED WITH HIV IN 2024. 630 000 [490 000-820 000] PEOPLE DIED FROM AIDS-RELATED ILLNESSES IN 2024. 31.6 MILLION PEOPLE [27.8-32.9 MILLION] WERE ACCESSING ANTIRETROVIRAL THERAPY IN 2024. 91.4 MILLION [73.4 MILLION-116.4 MILLION] PEOPLE HAVE BECOME INFECTED WITH HIV SINCE THE START OF THE EPIDEMIC. 44.1 MILLION [37.6 MILLION-53.4 MILLION] PEOPLE HAVE DIED FROM AIDS-RELATED ILLNESSES SINCE THE START OF THE EPIDEMIC." ACCORDING TO THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) 2025 UPDATE, THERE WERE OVER 39,000 PEOPLE NEWLY DIAGNOSED WITH HIV, ALMOST 4,500 HIV-RELATED DEATHS, AND OVER 1,132,000 AMERICANS LIVING WITH HIV BY THE END OF 2023.TAG'S HIV PROGRAM WORKS TO MAXIMIZE EQUITABLE, AFFORDABLE ACCESS TO THE TOOLS, SERVICES, POLICIES, AND APPROACHES TO PREVENTION AND CARE THAT ARE ESSENTIAL FOR THE GOAL OF ENDING THE HIV EPIDEMIC DOMESTICALLY AND GLOBALLY. ADVOCACY FOCUSED ON ENDING THE EPIDEMIC (ETE, OR EHE) IS AT THE CORE OF THE HIV PROGRAM'S WORK, FROM DRIVING THE NATION'S FIRST ETE INITIATIVE IN NEW YORK TO LEADING THE ACT NOW: END AIDS (ANEA) COALITION'S SUPPORT FOR PARTNERS IN HEAVILY BURDENED JURISDICTIONS IN THE SOUTHERN U.S. TAG'S HIV AND POLICY TEAMS TACKLE ISSUES AROUND DRUG PRICING AND EQUITABLE ACCESS TO EMERGING BIOMEDICAL INTERVENTIONS; FUNDING FOR EVIDENCE-BASED HIV PROGRAMMING; ACCESS TO HEALTHCARE; AND POLICIES THAT PROMOTE SAFE, INCLUSIVE ENVIRONMENTS THAT ARE FREE OF STIGMA AND DISCRIMINATION FOR PEOPLE TO SEEK PREVENTION AND CARE FOR HIV AND RELATED INFECTIONS, INCLUDING SEXUALLY TRANSMITTED INFECTIONS.TAG'S HIV PROGRAM LEADS RESEARCH ACTIVISM AND PROMOTES COMMUNITY ENGAGEMENT TO ENSURE THAT PEOPLE LIVING WITH HIV EVERYWHERE HAVE MORE OPTIONS INCLUDING, ULTIMATELY, A SAFE AND EFFECTIVE HIV VACCINE AND A CURE THAT ARE SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE. TAG'S HIV PROGRAM RECOGNIZES THAT EVEN THE MOST EFFECTIVE EXISTING PREVENTION AND TREATMENT INTERVENTIONS HAVE SHORTCOMINGS. TO THIS END, TAG'S BASIC SCIENCE, VACCINE AND CURE PROJECT TRACKS THE ANTIRETROVIRAL, CURE, IMMUNE-BASED THERAPY, AND BIOMEDICAL PREVENTION PIPELINES AND PUBLISHES ANNUAL REPORTS SUMMARIZING THEIR CURRENT STATUS. TAG ALSO PLAYS A VITAL LEADERSHIP ROLE IN BASIC SCIENCE, VACCINES, AND CURE ADVOCACY, PARTICIPATING IN COMMUNITY ADVISORY BOARDS AND ADMINISTERING AN EMAIL DISCUSSION LISTSERV FOR STAKEHOLDERS IN HIV CURE AND IMMUNE-BASED THERAPY RESEARCH. IN 2024, TAG CONTRIBUTED TO THE NEW U.S. NATIONAL INSTITUTES OF HEALTH (NIH) STRATEGIC PLAN FOR HIV AND HIV-RELATED RESEARCH, COVERING 2026-2030. DURING THE PLANNING PROCESS, TAG'S HIV PROJECT STAFF SERVED ON THE NIH OFFICE OF AIDS RESEARCH BASIC BIOMEDICAL AND PRECLINICAL RESEARCH TASKFORCE. TAG'S HIV CURE-RELATED CLINICAL TRIALS WEBSITE LISTING, UPDATED MONTHLY TO PROVIDE INFORMATION ON STUDIES AND THEIR RESULTS, IS WIDELY CITED IN SCIENTIFIC PAPERS AND IN CONFERENCE PRESENTATIONS. THE HIV PROGRAM ALSO ADVOCATES FOR APPROPRIATE INTERVENTIONS FOR PEOPLE WHO, DESPITE HIV TREATMENT, STILL HAVE POOR IMMUNE SYSTEM RECOVERY. CENTRAL TO THIS WORK IS ENSURING LEGISLATORS AND POLICY MAKERS UNDERSTAND THE ONGOING NEEDS FOR RESEARCH AND HIV-RELATED FUNDING, AND HOW IMPORTANT IT IS TO MAKE DECISIONS BASED ON SCIENTIFIC EVIDENCE.TAG STAFF CONTINUE TO PARTICIPATE AS MEMBERS OF THE PREP IN BLACK AMERICA COALITION, A NETWORK OF ADVOCATES WORKING TO INCREASE EQUITABLE ACCESS AND UPTAKE OF PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION, WHICH IN APRIL 2024 HOSTED A RESEARCH-FOCUSED PRE-CONFERENCE AHEAD OF THE NMAC BIOMEDICAL HIV PREVENTION SUMMIT. TAG ALSO CONTINUES TO LEAD AND CO-ORGANIZE COMMUNITY ENGAGEMENT ACTIVITIES ON HIV CURE RESEARCH, INCLUDING THE ANNUAL PRE-CROI COMMUNITY HIV CURE RESEARCH WORKSHOP, AND CONTINUES TO MAINTAIN THE ONLY KNOWN DATABASE MONITORI
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0906992
IRS990/ProgSrvcAccomActy2Grp/GrantAmt08308
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OHEPATITIS C VIRUS (HCV) PROGRAMACCORDING TO THE WORLD HEALTH ORGANIZATION'S GLOBAL HEPATITIS REPORT 2024, OF THE 50 MILLION PEOPLE ESTIMATED TO BE LIVING WITH CHRONIC HEPATITIS C VIRUS INFECTION, ONLY 36% WERE DIAGNOSED BETWEEN 2015 AND 2022, AND 20% RECEIVED TREATMENT. IN 2022 ALONE, ABOUT 1 MILLION NEW HCV INFECTIONS AND APPROXIMATELY 221 000 HCV-RELATED DEATHS WERE REGISTERED, MOSTLY FROM CIRRHOSIS AND HEPATOCELLULAR CARCINOMA.[1] ABOUT 2.3 MILLION PEOPLE (6.2%) OF THE ESTIMATED 37.7 MILLION LIVING WITH HIV GLOBALLY IN 2020 HAD SEROLOGICAL EVIDENCE OF PAST OR PRESENT HCV INFECTION.TAG'S HCV PROGRAM HAS BEEN AT THE FOREFRONT OF A GLOBAL HCV EDUCATION AND ADVOCACY MOVEMENT, WORKING IN COLLABORATION WITH AFFECTED COMMUNITIES, SCIENTISTS, GOVERNMENTS, AND DRUG COMPANIES TO MAKE LIFE-SAVING INFORMATION, HIGH QUALITY AND AFFORDABLE TESTING AND CURES, AND ENSURING A SUPPORTIVE ENVIRONMENT FOR UNDERSERVED POPULATIONS UNIVERSALLY. THIS INCLUDES TRACKING THE PIPELINE FOR HCV INNOVATIONS, INCLUDING THE LATEST PANGENOTYPIC TREATMENTS, DIAGNOSTICS, AND LONG-ACTING INJECTABLES, AND INCREASING COMMUNITIES' DIAGNOSTICS AND TREATMENT LITERACY. GLOBALLY, TAG PROVIDES TECHNICAL ASSISTANCE TO BUILD LEADERSHIP CAPACITY FOR ADVANCING NATIONAL ELIMINATION CAMPAIGNS AND AMPLIFYING COMMUNITY VOICES-ESPECIALLY THOSE OF KEY POPULATIONS SUCH AS PEOPLE WHO USE DRUGS, SEX WORKERS, PEOPLE IN INCARCERATION, MIGRANTS, AND MEN WHO HAVE SEX WITH MEN IN PLANNING AND POLICY DEVELOPMENT. TAG'S HCV PROGRAM WORKS TO OVERCOME BARRIERS TO HCV PREVENTION AND CARE, INCLUDING LIMITED DONOR FUNDING FOR HCV, RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, PATENTS, PRICING BARRIERS, INEFFECTIVE VOLUNTARY LICENSING AND DELAYS IN DRUG REGISTRATION BY ORIGINATOR COMPANIES. THE HCV PROGRAM ADVOCATES FOR HARM REDUCTION AND DRUG DECRIMINALIZATION EFFORTS, INCLUDING SUPPORT FOR OVERDOSE PREVENTION AND SAFE CONSUMPTION SITES AS UNSAFE INJECTION DRUG USE IS A MAJOR ROUTE OF HCV TRANSMISSION.IN THE U.S., TAG'S POLICY TEAM WORKS AT THE LOCAL, STATE, AND NATIONAL LEVELS: ADVOCATING FOR VIRAL HEPATITIS FUNDING, CHAMPIONING TREATMENT COVERAGE FOR PEOPLE WHO USE DRUGS, PEOPLE WHO ARE UNSTABLY HOUSED AND INCARCERATED OR OTHERWISE MARGINALIZED PEOPLE, ENCOURAGING VOLUME-BASED PRICING DEALS FOR DAAS, STRENGTHENING NATIONAL SURVEILLANCE, AND SUPPORTING COMMUNITY ENGAGEMENT. TAG'S ADVOCACY HELPED ADVANCE COVERAGE FOR UNIVERSAL ADULT HCV SCREENING AND DRIVE NEW YORK STATE'S COMMITMENT TO ELIMINATE HCV -- THE FIRST IN THE NATION! -- WITH TAG PARTICIPATING IN THE RESULTANT STATEWIDE HCV ELIMINATION TASK FORCE.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0297189
IRS990/ProgSrvcAccomActy3Grp/GrantAmt023179
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt022387
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt04682755
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0296958
IRS990/PYInvestmentIncomeAmt09829
IRS990/PYOtherExpensesAmt01121129

Document Assets

No mirrored PDF or thumbnail assets are attached yet.